Implantable Cardioverter-Defibrillators
Copyright policy )Implantable Cardioverter-Defibrillators
The automatic implantable cardioverter-defibrillator (AICD) is the most effective treatment for patients with life-threatening ventricular tachycardia or ventricular fibrillation. The American College of Cardiology/American Heart Association class I, IIa, and III indications for an AICD are discussed. Patients with AICDs should be treated with biventricular pacing, not with dual-chamber rate-responsive pacing at a rate of 70/minute. Patients with AICDs should be treated with beta blockers, statins, and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.
- New York Medical College United States
Angiotensin Receptor Antagonists, Adrenergic beta-Antagonists, Ventricular Fibrillation, Tachycardia, Ventricular, Humans, Angiotensin-Converting Enzyme Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Anti-Arrhythmia Agents, Defibrillators, Implantable
Angiotensin Receptor Antagonists, Adrenergic beta-Antagonists, Ventricular Fibrillation, Tachycardia, Ventricular, Humans, Angiotensin-Converting Enzyme Inhibitors, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Anti-Arrhythmia Agents, Defibrillators, Implantable
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).1 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!